Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
SGMT

Updated 10/6/2026, 8:56 AM ET.

SGMT

Sagimet Biosciences Inc.

Sale$3,591,580

Kemble George

Director

350,987 shat $10.23Filed Aug 17, 4:05 PM ET
Filing
SGMT

Sagimet Biosciences Inc.

Sale$201,147

Kemble George

Director

20,206 shat $9.95Filed Aug 12, 7:41 PM ET
Filing
SGMT

Sagimet Biosciences Inc.

Sale$497,068

Happel David

President & CEO, Director

64,051 shat $7.76Filed Jul 22, 4:05 PM ETFiling
SGMT

Sagimet Biosciences Inc.

Sale$81,832

Rozek Elizabeth

Chief Legal & Admin. Officer

10,545 shat $7.76Filed Jul 22, 4:05 PM ETFiling
SGMT

Sagimet Biosciences Inc.

Sale$140,529

Kemble George

Director

18,844 shat $7.46Filed Jul 22, 4:05 PM ET
Filing

Read from public SEC filings. Not financial advice.